PXN has been shown to be a prognostic factor in patients with colorectal cancer, laryngeal squamous cell carcinoma, and squamous cell/adenosquamous carcinoma [14, 15]. This evidence concerns the gene PXN and laryngeal squamous cell carcinoma.